Quantitative real-time PCR for detection of neurotoxin genes of Clostridium botulinum types A, B and C in equine samples.
Authors: Johnson Amy L, McAdams-Gallagher Susan C, Sweeney Raymond W
Journal: Veterinary journal (London, England : 1997)
Summary
Detection of equine botulism has traditionally relied on the mouse bioassay, a time-consuming and ethically problematic method; Johnson and colleagues developed and validated quantitative real-time PCR assays capable of identifying the neurotoxin genes of *Clostridium botulinum* types A, B and C in gastrointestinal, faecal and feed samples from affected horses. Using 148 well-characterised diagnostic samples (106 positive, 42 negative), the researchers compared their duplex qPCR protocol for types A and B and singleplex assay for type C against the gold-standard mouse bioassay, finding sensitivities of 89%, 86% and 96% respectively—marginally superior to the bioassay's 81% overall sensitivity—whilst maintaining exceptional specificity of 99–100% across all three types. Beyond its superior diagnostic accuracy, the qPCR approach offers substantial practical advantages: results can be generated within hours rather than days, eliminates animal use, and allows simultaneous testing for multiple toxin types from a single sample. For practitioners managing suspected botulism cases, these assays provide a faster, more definitive pathway to diagnosis and appropriate treatment planning, though integration into routine equine diagnostic laboratories will depend on technical capacity and cost considerations in individual settings.
Read the full abstract on PubMed
Practical Takeaways
- •qPCR offers a faster, more sensitive alternative to mouse bioassay for diagnosing botulism in horses, enabling quicker treatment decisions
- •These assays can reliably identify botulism types A, B, and C from feed, faecal and GI samples, helping determine toxin source and guide feed management
- •The high specificity (99-100%) means positive qPCR results are highly reliable for confirming botulism diagnosis in clinical cases
Key Findings
- •Duplex qPCR for C. botulinum types A and B showed sensitivities of 89% and 86% respectively, with 99-100% specificity
- •Singleplex qPCR for C. botulinum type C achieved 96% sensitivity with 100% specificity
- •qPCR assays demonstrated superior or equivalent performance to standard mouse bioassay (overall sensitivity 81%, specificity 95%) for detecting neurotoxin genes
- •qPCR successfully detected toxin genes in equine gastrointestinal, faecal and feed samples from 106 positive cases including types A, B, C, D and E